Get the Latest!
Join Our Newsletter
Complete the form to receive quarterly information from the National Stem Cell Association.
All fields required.
Supporting doctors and clinicians so that you can support your patients.
The association will provide new tips on marketing on social media and other formats. It will also work to ensure maximum access to all social media platforms for existing stem cell providers. Depending upon your membership level, members can link with the NSCA web page and provide high level information on their practice and live testimonials, in addition to linking with the member’s web page directly. Membership in the NSCA will eventually become a standard of excellence and safety for the public because the association will capture each member’s future clinical data through new registries. And the NSCA will actively promote the safety record of its members to the public and among regulators.
Additionally, through its own research externally and internally, and through exchange of information among members, the NSCA will continuously provide updates to enhance clinical outcomes and highlight “best practices”, both from a safety and efficacy perspective. There is an overwhelming amount of outstanding research and clinical trials in progress around the world. The NSCA will condense and highlight developments that are most likely to be important and relevant for your practice today.
The NSCA will also:
There is a significant amount of superb published data on stem cell research, clinical trials, and patient results, and the scientific literature grows daily. However, a large portion of the data is not helpful or practical for ongoing regenerative therapy today, and not all of it is positive or accurate. Preliminary efforts by NSCA will include sorting through existing and newly published research for its members, highlighting useful and practical insights that can help members improve results for their patients in terms of efficacy and safety, and also add credibility to the marketing message being employed by most members. Moreover, there is a substantial amount of positive and useful data within NSCA’s own membership network which will also be accumulated and analyzed, especially over time, further improving outcomes and safety for each member.
As NSCA grows, long term plans include forming a separate non-profit organization through a 501(C)3 to perform original research using NSCA’s own scientists and clinicians, again focused primarily on issues that are highly relevant to the daily practice of regenerative medicine by its members. As a 501(C)3, this organization will be able to raise funds through separate research grants and other government programs designed to support creation of objective scientific research.
While there is an enormous amount of anecdotal data regarding regenerative stem cell therapy, most clinics also have a large repository of professional videos from their most satisfied clients. With permission from the clinic and from the patient, and also ensuring that any legal issues are reviewed and addressed, NSCA will select the top 10% of these videos and make them available to web site visitors to improve credibility of the current universe of regenerative medicine providers. For Founder’s Committee and Executive Committee members, links will be established directly with each member’s web page allowing secure testimonials to be attributed to the particular clinic for marketing and advertising purposes.
NSCA intends to facilitate the creation of multiple registries for its members – all sponsored by reputable national IRB’s – in order to permit its members to create verifiable clinical data that their regenerative therapies are effective and safe. NSCA intends to absorb most of the administrative burden in creating and administering these registries, so that the members receive the benefits but not the economic constraints.
NSCA strongly believes that extensive use of registries by its members will be the key to establishing long-term confidence in the industry, and those that continue to operate without verifiable clinical evidence of the efficacy of their treatment regimens, and more importantly the general safety of their treatment regimens, will likely be subject to direct intervention by the FDA and other regulatory authorities and the possible cessation of their regenerative medicine practice. This is already a very credible threat to everyone practicing regenerative medicine in the U.S. today.
One of the primary missions of NSCA is convince regulators and the public that current stem cell therapy is safe, and to ensure that current and improved forms of regenerative medicine exist for patients who need it for many years to come.
No scheduled events at this time.